Core Specialty IPO: Son of Validus refracted through an AFG lens
  • X
  • LinkedIn
  • Show more sharing options
  • Print
  • X
  • LinkedIn
  • Free Trial
  • Log in

Core Specialty IPO: Son of Validus refracted through an AFG lens

“Consoloonan” are set to return to the public markets over a decade after their last conference call.

By Adam McNestrie Husain Rupawala
September 04, 2024
  • X
  • LinkedIn
  • Show more sharing options
  • Print
  • X
  • LinkedIn
Jeff Consolino and Ed Noonan
Jeff Consolino and Ed Noonan

Last week Insurance Insider US revealed that Core Specialty – the Class of 2020 recap led by Jeff Consolino and Ed Noonan (“Consoloonan”) – was limbering up for a Q4 IPO.

After

Request a free trial:

Fuel a smarter strategy with our actionable market intelligence

    • Gain a competitive edge and accelerate decision-making
    • Be empowered by insights that transform confusion to clarity
    • Uncover growth opportunities and prepare for potential threats
Request a free trial Already a subscriber? Log in now

Topics

OpinionCore Specialty
Gift this article